alanine has been researched along with Amentia in 9 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A double-blind parallel comparison of alaproclate and placebo was carried out in patients suffering from senile dementia of primary degenerative type, or multiinfarction dementia." | 9.05 | A double-blind comparison of alaproclate and placebo in the treatment of patients with senile dementia. ( Dehlin, O; Hedenrud, B; Jansson, P; Nörgård, J, 1985) |
| "Alaproclate, a specific inhibitor of neuronal serotonin re-uptake, was given to 12 patients with dementia of Alzheimer type." | 7.66 | Alaproclate: a pharmacokinetic and biochemical study in patients with dementia of Alzheimer type. ( Bergman, I; Bråne, G; Gottfries, CG; Jostell, KG; Karlsson, I; Svennerholm, L, 1983) |
| "A double-blind parallel comparison of alaproclate and placebo was carried out in patients suffering from senile dementia of primary degenerative type, or multiinfarction dementia." | 5.05 | A double-blind comparison of alaproclate and placebo in the treatment of patients with senile dementia. ( Dehlin, O; Hedenrud, B; Jansson, P; Nörgård, J, 1985) |
| "Alaproclate, a specific inhibitor of neuronal serotonin re-uptake, was given to 12 patients with dementia of Alzheimer type." | 3.66 | Alaproclate: a pharmacokinetic and biochemical study in patients with dementia of Alzheimer type. ( Bergman, I; Bråne, G; Gottfries, CG; Jostell, KG; Karlsson, I; Svennerholm, L, 1983) |
| "To study parkinsonism, dementia, dystonia, and amyotrophy as subphenotypes of SCA2, and to explore the effect of CAG repeats at different loci and of mitochondrial polymorphism A10398G as modifiers of phenotype." | 1.46 | Neurological phenotypes in spinocerebellar ataxia type 2: Role of mitochondrial polymorphism A10398G and other risk factors. ( Augustin, MC; Barsottini, O; Jardim, LB; Locks-Coelho, LD; Monte, TL; Pedroso, JL; Pereira, FS; Reckziegel, EDR; Santos, ASP; Saraiva-Pereira, ML; Vargas, FR, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Monte, TL | 1 |
| Pereira, FS | 1 |
| Reckziegel, EDR | 1 |
| Augustin, MC | 1 |
| Locks-Coelho, LD | 1 |
| Santos, ASP | 1 |
| Pedroso, JL | 1 |
| Barsottini, O | 1 |
| Vargas, FR | 1 |
| Saraiva-Pereira, ML | 1 |
| Jardim, LB | 1 |
| McAninch, EA | 1 |
| Rajan, KB | 1 |
| Evans, DA | 1 |
| Jo, S | 1 |
| Chaker, L | 1 |
| Peeters, RP | 1 |
| Bennett, DA | 1 |
| Mash, DC | 1 |
| Bianco, AC | 1 |
| Arnold, SE | 1 |
| Vega, IE | 1 |
| Karlawish, JH | 1 |
| Wolk, DA | 1 |
| Nunez, J | 1 |
| Negron, M | 1 |
| Xie, SX | 1 |
| Wang, LS | 1 |
| Dubroff, JG | 1 |
| McCarty-Wood, E | 1 |
| Trojanowski, JQ | 2 |
| Van Deerlin, V | 1 |
| Arpa, A | 1 |
| del Ser, T | 1 |
| Goda, G | 1 |
| Barba, R | 1 |
| Bornstein, B | 1 |
| Jimenez-Escrig, A | 1 |
| Rabano, A | 1 |
| Guerrero, C | 1 |
| Simon, J | 1 |
| Barquero, MS | 1 |
| Güell, I | 1 |
| Ginestal, RC | 1 |
| Montero, T | 1 |
| Orensanz, L | 1 |
| Van Deerlin, VM | 1 |
| Leverenz, JB | 1 |
| Bekris, LM | 1 |
| Bird, TD | 1 |
| Yuan, W | 1 |
| Elman, LB | 1 |
| Clay, D | 1 |
| Wood, EM | 1 |
| Chen-Plotkin, AS | 1 |
| Martinez-Lage, M | 1 |
| Steinbart, E | 1 |
| McCluskey, L | 1 |
| Grossman, M | 1 |
| Neumann, M | 1 |
| Wu, IL | 1 |
| Yang, WS | 1 |
| Kalb, R | 1 |
| Galasko, DR | 1 |
| Montine, TJ | 1 |
| Lee, VM | 1 |
| Schellenberg, GD | 1 |
| Yu, CE | 1 |
| Bergman, I | 1 |
| Bråne, G | 1 |
| Gottfries, CG | 1 |
| Jostell, KG | 1 |
| Karlsson, I | 1 |
| Svennerholm, L | 1 |
| Bottiglieri, T | 1 |
| Parnetti, L | 1 |
| Arning, E | 1 |
| Ortiz, T | 1 |
| Amici, S | 1 |
| Lanari, A | 1 |
| Gallai, V | 1 |
| Dehlin, O | 1 |
| Hedenrud, B | 1 |
| Jansson, P | 1 |
| Nörgård, J | 1 |
1 review available for alanine and Amentia
| Article | Year |
|---|---|
A Common DIO2 Polymorphism and Alzheimer Disease Dementia in African and European Americans.
Topics: Aged; Aged, 80 and over; Alanine; Alzheimer Disease; Amino Acid Substitution; Black or African Ameri | 2018 |
1 trial available for alanine and Amentia
| Article | Year |
|---|---|
A double-blind comparison of alaproclate and placebo in the treatment of patients with senile dementia.
Topics: Aged; Alanine; Clinical Trials as Topic; Dementia; Double-Blind Method; Female; Humans; Intelligence | 1985 |
7 other studies available for alanine and Amentia
| Article | Year |
|---|---|
Neurological phenotypes in spinocerebellar ataxia type 2: Role of mitochondrial polymorphism A10398G and other risk factors.
Topics: Adult; Aged; Alanine; Ataxin-2; Dementia; Dystonia; Female; Genetic Predisposition to Disease; Glyci | 2017 |
Frequency and clinicopathological characteristics of presenilin 1 Gly206Ala mutation in Puerto Rican Hispanics with dementia.
Topics: Aged; Aged, 80 and over; Alanine; Dementia; Female; Gene Frequency; Genetic Carrier Screening; Glyci | 2013 |
Apolipoprotein E, angiotensin-converting enzyme and alpha-1-antichymotrypsin genotypes are not associated with post-stroke dementia.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Alleles; alpha 1-Antitrypsin; Apolipoproteins E; Cysteine; | 2003 |
New V272A presenilin 1 mutation with very early onset subcortical dementia and parkinsonism.
Topics: Adult; Alanine; Amyloid beta-Peptides; Brain; Dementia; DNA Mutational Analysis; Family Health; Fema | 2004 |
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Amyotrophic Lateral Sclerosis; Brain; Child; De | 2008 |
Alaproclate: a pharmacokinetic and biochemical study in patients with dementia of Alzheimer type.
Topics: Aged; Alanine; Alzheimer Disease; Dementia; Female; Humans; Kinetics; Male; Serotonin | 1983 |
Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: a study in an Italian population with dementia.
Topics: Aged; Alanine; Dementia; Female; Folic Acid; Homocysteine; Humans; Italy; Male; Methylenetetrahydrof | 2001 |